A superoxide anion-specific chemiluminescent probe for detection of acute inflammation.
Biomarker-responsive chemiluminescence (CL) probes have been developed as a promising technology for noninvasive bioimaging of diseases. Based on the high sensitivity of CL imaging technology, a boron dipyrromethene (BODIPY)-based CL probe (BDPH1) with a hydroxypyridine group was designed for the detection of superoxid...